NCT06249633

Inhaled Nitric Oxide for ARDS-related Pulmonary Hypertension

A Pilot Study of Inhaled Nitric Oxide for ARDS-related Pulmonary Hypertension

• Status: Unknown
• Phase: EARLY_Phase 1
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Yuri Matusov · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Open-label pilot study of early inhaled nitric oxide (iNO) for patients developing de novo pulmonary hypertension during Acute Respiratory Distress Syndrome (ARDS.) The study aims to determine whether iNO has possible hemodynamic and clinical benefits when given early in the course of ARDS to patients with evidence of elevated pulmonary artery pressure.

Conditions

• Acute Respiratory Distress Syndrome
• Pulmonary Hypertension

Interventions

Type	Name	Description
DRUG	Nitric Oxide	Inhaled nitric oxide

Timeline

• Start date: 2024-02-01
• Primary completion: 2026-02-01
• Completion: 2026-02-01
• First posted: 2024-02-08
• Last updated: 2024-02-08

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study